Stock screener

RIGL

Conviction 89HealthcareScan · Mon, Aug 10, 2026
RIGL$41.64+3.66%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 347.66K
May 11May 28Jun 16Jul 6Jul 23Aug 10
RIGEL PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.rigel.com ↗
Price41.64
Change+3.66%
Gap+1.10%
Rel volume1.87×
Avg volume336.56K
Avg $ vol13.23M
SMA 2039.12
SMA 5036.88
SMA 20035.30
Price vs 50+12.90%
Price vs 200+17.95%
MA stackbullish
50/200 cross—
Supertrendup · 34.44
RSI (14)62
MACD hist0.10
MACD crossbull · 0d
Stoch %K / %D78 / 63
ADX (14)24
+DI / −DI32 / 15
RSI divergence—
MACD divergence—
ATR %+4.94%
ADR %4.90%
52w high50.96
52w low25.44
From 52w high-18.29%
Above 52w low+63.68%
New 52w highNo
SqueezeOff
Bollinger width16.52%
%B0.89
Donchian pos78.20%
Donchian high43.49
Donchian low35.01
AVWAP (52w high)35.69
vs AVWAP high+16.66%
AVWAP (52w low)33.14
vs AVWAP low+25.63%
OBV trendFlat
Chaikin MF (20)-0.05
Today vs 20d1.87×
Avg vol (14d)347.66K
Avg vol (20d)336.56K
Avg $ vol (20d)13.23M
Market cap777.83M
RS 3m (vs SPY)+47.39%
RS 6m (vs SPY)+6.81%
RS line new highNo
Trend template6/8
Technical rank78.0
1 week+11.25%
1 month-2.14%
3 months+59.91%
6 months+21.93%
1 year+36.79%
YTD-0.45%
P/E2.12
P/B1.83
P/S2.64
P/FCF10.34
EPS19.48
Div yield—
ROE86.27%
ROA70.44%
Debt/Eq0.11
Current1.94
EV/EBITDA5.96
Gross margin5.92%
Net margin124.72%
Rev growth64.15%
EPS growth1999.08%
Price target55.75
Target upside33.89%
Analyst ratingBuy
Institutional92.79%
Ent. value762.01M
Revenue78.7M
Net income17.29M
Gross profit—
Free cash flow75.2M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out18.5M
Employees174
ListedWed, Nov 29, 2000
Free float16.56M
Float %89.5%
Short interest3.16M
Days to cover7.9d
Short volume73.8%
Squeeze score96 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.88 vs $0.91
Last surprise-3.3% miss
Setup gradeA+
Conviction89 / 100
Pattern quality—
Tech rank78.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance43.74
Support33.40
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RIGL

All disclosures →
No recent disclosed trades by Congress in RIGL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RIGL · 8 buys · 2 sells

InsiderSideShares
HANNAH ALISON L.
EVP, Chief Medical Officer · Common Stock · 2026-07-08
Grant24.4K
Ali-Jackson Kamil
Director · Common Stock · 2026-06-22
Sell2.5K
Schorno Dean L
EVP & Chief Financial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Furey Raymond J.
EVP, GC, CCO & Corp Sec · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
Santos David A
EVP, Chief Commercial Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Employee Stock Option (right to buy) · 2026-06-17
Grant31.7K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant9.38K
Rojkjaer Lisa
EVP, Chief Medical Officer · Employee Stock Option (right to buy) · 2026-06-17
Grant7.39K
RODRIGUEZ RAUL R
CEO, President · Common Stock · 2026-06-01
Tax2.42K
Schorno Dean L
EVP & Chief Financial Officer · Common Stock · 2026-06-01
Exercise1.2K

SEC filings

EDGAR filings in RIGL · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.